by Neoteryx | 2 min read
The ongoing COVID-19 pandemic has spawned significant changes in our healthcare sector. The most notable change has been accelerated adoption of the fingerstick method for remote blood collection. This technique allows patients …
Read Storyby Neoteryx | 4 min read
Recent studies show that people with type A blood may be more susceptible to COVID-19 illness than those with other blood types. Researchers in China reached this conclusion after studying …
Read Storyby Neoteryx | 3 min read
The COVID-19 crisis has forced many to adapt to a new lifestyle; one that adheres to social distancing regulations to avoid cross-contamination. As you can imagine, the coronavirus pandemic has …
Read Storyby Neoteryx | 3 min read
Like many physicians, you may be preparing to reopen your medical practice and welcome patients back for in-person visits. Due to the coronavirus pandemic, most medical practitioners were limiting in-person …
Read Storyby Neoteryx | 3 min read
The number of people that need to be tested for COVID-19 continues to overwhelm public health facilities and laboratories that perform testing. Veterinary diagnostic laboratories with adequate staff and infrastructure …
Read Storyby Neoteryx | 3 min read
Local governments and states have implemented restrictions to reduce transmission of the deadly coronavirus known as SARS-CoV-2, which causes COVID-19 illness. Their early efforts paid off; the curve flattened in …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.